Diloxanide furoate

WikiDoc Resources for Diloxanide furoate
Articles
Most recent articles on Diloxanide furoate Most cited articles on Diloxanide furoate Review articles on Diloxanide furoate Articles on Diloxanide furoate in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Diloxanide furoate Images of Diloxanide furoate Photos of Diloxanide furoate Podcasts & MP3s on Diloxanide furoate Videos on Diloxanide furoate
Evidence Based Medicine
Cochrane Collaboration on Diloxanide furoate Bandolier on Diloxanide furoate TRIP on Diloxanide furoate
Clinical Trials
Ongoing Trials on Diloxanide furoate at Clinical Trials.gov Trial results on Diloxanide furoate Clinical Trials on Diloxanide furoate at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Diloxanide furoate NICE Guidance on Diloxanide furoate NHS PRODIGY Guidance FDA on Diloxanide furoate CDC on Diloxanide furoate
Books
Books on Diloxanide furoate
News
Diloxanide furoate in the news Be alerted to news on Diloxanide furoate News trends on Diloxanide furoate
Commentary
Blogs on Diloxanide furoate
Definitions
Definitions of Diloxanide furoate
Patient Resources / Community
Patient resources on Diloxanide furoate Discussion groups on Diloxanide furoate Patient Handouts on Diloxanide furoate Directions to Hospitals Treating Diloxanide furoate Risk calculators and risk factors for Diloxanide furoate
Healthcare Provider Resources
Symptoms of Diloxanide furoate Causes & Risk Factors for Diloxanide furoate Diagnostic studies for Diloxanide furoate Treatment of Diloxanide furoate
Continuing Medical Education (CME)
CME Programs on Diloxanide furoate
International
Diloxanide furoate en Espanol Diloxanide furoate en Francais
Business
Diloxanide furoate in the Marketplace Patents on Diloxanide furoate
Experimental / Informatics
List of terms related to Diloxanide furoate

Diloxanide furoate is an anti-protozoal drug used in the treatment of Entamoeba histolytica and some other protozoal infections.

Safety and Effectiveness

A 13-year study conducted by the United States Center for Disease Control between 1977 and 1990 found that this drug had a low incidence of side effects and was successful in treatment of 86% of asymptomatic carriers of Entamoeba histolytica.

Availability by Country

United States: Not currently approved for use. A CDC study authorized the use of this drug in the treatment of 4,371 cases of Entamoeba histolytica from 1977 to 1990.

References

Template:WikiDoc Sources